Development and clinical evaluation of AFP-L3% as a new tumor marker for hepatocellular carcinoma

被引:0
|
作者
Wang, YY
Kanke, F
Kato, H
Wise, MG
Mallory, TS
Satomura, S
机构
[1] Wako Pure Chem Ind Ltd, Richmond, VA USA
[2] Wako Chem USA, Richmond, VA USA
[3] Wako Pure Chem Ind Ltd, Osaka, Japan
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:A58 / A58
页数:1
相关论文
共 50 条
  • [11] Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
    Park, Sang Joon
    Jang, Jae Young
    Jeong, Soung Won
    Cho, Young Kyu
    Lee, Sae Hwan
    Kim, Sang Gyune
    Cha, Sang-Woo
    Kim, Young Seok
    Cho, Young Deok
    Kim, Hong Soo
    Kim, Boo Sung
    Park, Suyeon
    Bang, Hae In
    MEDICINE, 2017, 96 (11)
  • [12] AFP-L3 for the diagnosis of early hepatocellular carcinoma A meta-analysis
    Zhou, Jian-Ming
    Wang, Ting
    Zhang, Kun-He
    MEDICINE, 2021, 100 (43) : E27673
  • [13] AFP-L3% as a biomarker for early recognition of rapidly growing hepatocellular carcinoma
    Wang, Y
    Satomura, S
    Wise, M
    Kanke, F
    Mallory, T
    Schwartz, M
    Sterling, R
    Jeffers, L
    Gordon, F
    Reddy, R
    Venook, AP
    Sherman, M
    HEPATOLOGY, 2005, 42 (04) : 390A - 390A
  • [14] Diagnostic value of AFP-L3 and PIVKA-Ⅱin hepatocellular carcinoma according to total-AFP
    Jong Young Choi
    Seung Won Jung
    Hee Yeon Kim
    Myungshin Kim
    Yonggoo Kim
    Dong Goo Kim
    Eun-Jee Oh
    World Journal of Gastroenterology, 2013, (03) : 339 - 346
  • [15] Sublingual vein parameters, AFP, AFP-L3, and GP73 in patients with hepatocellular carcinoma
    Zhao, J.
    Guo, L. -Y.
    Yang, J. -M.
    Jia, J. -W.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 7062 - 7067
  • [16] THE VALUE OF COMBINED DETECTION OF PIVKA-II, AFP AND AFP-L3 IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA
    Pan, Yongjie
    Dai, Jinhua
    Hua, Xin
    Chew, Junfeng
    Chew, Yanmin
    Liao, Yufeng
    ACTA MEDICA MEDITERRANEA, 2019, 35 (05): : 2793 - 2797
  • [17] Significance of hepatic progenitor cell marker-positive hepatocellular carcinoma and its possible prediction by AFP-L3
    Tsuchiya, Atsunori
    Kojima, Yuichi
    Seino, Satoshi
    Watanabe, Yusuke
    Kamimura, Kenya
    Takamura, Masaaki
    Kawai, Hirokazu
    Yamagiwa, Satoshi
    Terai, Shuji
    HEPATOLOGY, 2016, 64 : 669A - 670A
  • [18] Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP
    Choi, Jong Young
    Jung, Seung Won
    Kim, Hee Yeon
    Kim, Myungshin
    Kim, Yonggoo
    Kim, Dong Goo
    Oh, Eun-Jee
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (03) : 339 - 346
  • [19] Estimation of telomerase, AFP, and AFP-L3 levels in Sudanese patients with hepatocellular carcinoma and chronic liver diseases
    Rahamtalla F.A.
    Abdalla M.S.M.
    Mudawi S.B.M.
    Kheir Elsid M.A.H.
    Shammat I.M.
    Comparative Clinical Pathology, 2018, 27 (5) : 1133 - 1140
  • [20] Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients
    Lim, Tae Seop
    Kim, Do Young
    Han, Kwang-Hyub
    Kim, Hyon-Suk
    Shin, Seung Hwan
    Jung, Kyu Sik
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Ahn, Sang Hoon
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (03) : 344 - 353